BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
—Supports BioCryst’s evolution toward a more disciplined R&D model centered on external innovation—
—Supports BioCryst’s evolution toward a more disciplined R&D model centered on external innovation—